Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-017250
Filing Date
2019-05-08
Accepted
2019-05-08 16:31:36
Documents
54
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q arav-10q_20190331.htm 10-Q 1117894
2 EX-31.1 arav-ex311_9.htm EX-31.1 16610
3 EX-31.2 arav-ex312_6.htm EX-31.2 16510
4 EX-32.1 arav-ex321_7.htm EX-32.1 7196
5 EX-32.2 arav-ex322_8.htm EX-32.2 7124
  Complete submission text file 0001564590-19-017250.txt   4400155

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arav-20190331.xml EX-101.INS 861306
7 XBRL TAXONOMY EXTENSION SCHEMA arav-20190331.xsd EX-101.SCH 39354
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arav-20190331_cal.xml EX-101.CAL 41074
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arav-20190331_def.xml EX-101.DEF 97722
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arav-20190331_lab.xml EX-101.LAB 320354
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arav-20190331_pre.xml EX-101.PRE 224807
Mailing Address LYONDELLBASELL TOWER 1221 MCKINNEY STREET, SUITE 3200 HOUSTON TX 77010
Business Address LYONDELLBASELL TOWER 1221 MCKINNEY STREET, SUITE 3200 HOUSTON TX 77010 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

EIN.: 264106690 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36361 | Film No.: 19807080
SIC: 2834 Pharmaceutical Preparations